Amicogen, Inc. (KOSDAQ:092040)
 3,040.00
 -40.00 (-1.30%)
  Oct 31, 2025, 1:39 PM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 170.22 billion as of October 30, 2025. Its market cap has decreased by -34.63% in one year.
Market Cap 
 170.22B
Enterprise Value 
 272.51B
Revenue 
 117.72B
Ranking 
 n/a
PE Ratio 
 n/a
Stock Price 
3,040.00
Market Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 170.22B, a decrease of -28.23%. That is a compound annual growth rate of -2.70%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 170.22B | -19.55% | 
| Dec 30, 2024 | 211.59B | -48.65% | 
| Dec 28, 2023 | 412.06B | 8.63% | 
| Dec 29, 2022 | 379.32B | -38.89% | 
| Dec 30, 2021 | 620.70B | -14.98% | 
| Dec 30, 2020 | 730.08B | 50.94% | 
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro | 
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Samsung Biologics | 87.69T | 
| Celltrion | 39.50T | 
| ALTEOGEN | 25.46T | 
| SK Biopharmaceuticals | 9.08T | 
| Yuhan | 8.94T | 
| HLB Co., Ltd. | 6.25T | 
| Peptron | 6.06T | 
| PharmaResearch | 5.57T |